Variable | Overall survival | Progression-free survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Primary site (extra-nasal vs. nasal) | 1.860 | 1.092–3.169 | 0.022 | 1.857 | 1.182–2.916 | 0.007 |
Regional lymph node involvement (yes vs. no) | 1.796 | 1.080–2.986 | 0.024 | 1.716 | 1.116–2.637 | 0.014 |
Age (>60 vs. ≤60 years) | 3.365 | 1.867–6.066 | <0.001 | 1.720 | 0.984–3.006 | 0.057 |
Elevated LDH level (yes vs. no) | 2.422 | 1.419–4.132 | 0.001 | 1.942 | 1.218–3.093 | 0.005 |
ECOG score (≥2 vs. 0–1) | 2.439 | 1.410–5.690 | 0.040 | – | – | – |